Huang, K.-W.; Tan, C.P.; Reebye, V.; Chee, C.E.; Zacharoulis, D.; Habib, R.; Blakey, D.C.; Rossi, J.J.; Habib, N.; Sodergren, M.H.
MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models. Int. J. Mol. Sci. 2021, 22, 9168.
https://doi.org/10.3390/ijms22179168
AMA Style
Huang K-W, Tan CP, Reebye V, Chee CE, Zacharoulis D, Habib R, Blakey DC, Rossi JJ, Habib N, Sodergren MH.
MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models. International Journal of Molecular Sciences. 2021; 22(17):9168.
https://doi.org/10.3390/ijms22179168
Chicago/Turabian Style
Huang, Kai-Wen, Choon Ping Tan, Vikash Reebye, Cheng Ean Chee, Dimitris Zacharoulis, Robert Habib, David C. Blakey, John J. Rossi, Nagy Habib, and Mikael H. Sodergren.
2021. "MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models" International Journal of Molecular Sciences 22, no. 17: 9168.
https://doi.org/10.3390/ijms22179168
APA Style
Huang, K. -W., Tan, C. P., Reebye, V., Chee, C. E., Zacharoulis, D., Habib, R., Blakey, D. C., Rossi, J. J., Habib, N., & Sodergren, M. H.
(2021). MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models. International Journal of Molecular Sciences, 22(17), 9168.
https://doi.org/10.3390/ijms22179168
